A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

OBJECTIVE: In this study, we evaluated the efficacy of hydroxychloroquine (HCQ) against coronavirus disease 2019 (COVID-19) via a randomized controlled trial (RCT) and a retrospective study. METHODS: Subjects admitted to 11 designated public hospitals in Taiwan between April 1 and May 31, 2020, with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng-Pin, Lin, Yi-Chun, Chen, Tsung-Chia, Tseng, Ting-Yu, Wong, Hon-Lai, Kuo, Cheng-Yu, Lin, Wu-Pu, Huang, Sz-Rung, Wang, Wei-Yao, Liao, Jia-Hung, Liao, Chung-Shin, Hung, Yuan-Pin, Lin, Tse-Hung, Chang, Tz-Yan, Hsiao, Chin-Fu, Huang, Yi-Wen, Chung, Wei-Sheng, Cheng, Chien-Yu, Cheng, Shu-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710068/
https://www.ncbi.nlm.nih.gov/pubmed/33264337
http://dx.doi.org/10.1371/journal.pone.0242763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710068/
https://www.ncbi.nlm.nih.gov/pubmed/33264337
http://dx.doi.org/10.1371/journal.pone.0242763

Ejemplares similares